Conduit Pharmaceuticals Inc. (CDT)
Market Closed
10 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
CXA $
3. 11
-0.31
-9.0643%
Pre Market
$
+0.08 +2.5723% 3. 19
1.66M Market Cap
- P/E Ratio
- Div Yield
40,709 Volume
- Eps
$ 3.42
Previous Close 
Want to track CDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Conduit Pharmaceuticals Inc. (CDT) Statistics
Valuation metrics
Market Cap 1.66M
Enterprise value 972.23M
Trailing P/E (ttm) 0.04
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0
Price/Book (mrq) 0.1
Enterprise Value/Revenue 0.67
Enterprise Value/EBITDA 4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 57.23K
Average volume (90 days) 7.57M
Price summary
52-Week low 2.53
52-Week high 3,700
Beta -
50-Day moving average 1.47
200-Day moving average 1.85
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.06
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 20 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.06%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 37.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.97
Total debt (mrq) -
Total Debt/Equity (mrq) 0.95
Current ratio (mrq) 2.14%
Book value per share (mrq) 35.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
